Wegovy 0.5

Wegovy 0.5mg FlexTouch is used for cardiovascular risk reduction and weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have at least one related health condition. It works best when combined with a balanced diet and regular physical activity. In addition, it is used for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults. Wegovy 0.5mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits. The most common side effects of Wegovy 0.5mg FlexTouch include nausea, vomiting, diarrhea, and constipation. These are usually mild to moderate and tend to improve as the body adjusts to treatment. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your docto

Risk Reduction of Heart disease Management of Obesity Treatment of Metabolic dysfunction-associated steatohepatitis (MASH)

Wegovy 0.5mg FlexTouch comes in a prefilled pen designed for self-administration and is convenient to use. However, speak with your doctor or healthcare provider for proper training, either for you or your caregiver, to ensure safe and effective use at home.

Risk Reduction of Heart disease Wegovy 0.5mg FlexTouch helps lower the risk of serious heart-related problems such as heart attack, stroke, or cardiovascular death in adults who already have heart disease and are overweight or obese. It works by improving body weight, blood sugar levels, and other metabolic factors that contribute to the development of heart disease. When used along with a reduced-calorie diet and regular physical activity, it may help reduce cardiovascular risk. Management of Obesity Wegovy 0.5mg FlexTouch supports long-term weight loss and weight maintenance in adults with obesity, adults with overweight who have at least one weight-related health condition, and adolescents aged 12 years and older with obesity. It helps reduce appetite, helping one feel full sooner. This lowers food cravings and makes it easier to follow a reduced-calorie eating plan and stay consistent with lifestyle changes. Over time, this can lead to weight loss and help prevent weight-related complications.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Wegovy Nausea Vomiting Diarrhea Constipation

2 - 8°C